Patent systems around the world apply markedly different standards to the patentability of pharmaceutical inventions, particularly with regard to second medical use claims. 

Some jurisdictions adopt a restrictive approach to inventive step, sufficiency of disclosure and claim format, while others are more permissive.

This session will compare these approaches across key regions and examine their practical impact on claim drafting, prosecution strategy and enforcement. 

Topics will include assessing inventive step in pharmaceutical cases, the use of post-published evidence, the evolution of sufficiency standards and the current debates surrounding dosage claims and in vivo data.

With speakers from Asia, Europe, North America and South America, the session offers a truly global perspective on how different patentability standards influence pharmaceutical innovation and protection strategies worldwide.